A5070516370- Respiratory and Cough-Related Research
- Asthma and respiratory diseases
- Respiratory Support and Mechanisms
- Eosinophilic Esophagitis
- Tuberculosis Research and Epidemiology
- Voice and Speech Disorders
- Systemic Sclerosis and Related Diseases
- Advanced Chemical Sensor Technologies
- Gout, Hyperuricemia, Uric Acid
- Adrenal Hormones and Disorders
- Pleural and Pulmonary Diseases
- SARS-CoV-2 and COVID-19 Research
- Urticaria and Related Conditions
- Indigenous Studies and Ecology
- Human Health and Disease
- Aortic aneurysm repair treatments
- Kruppel-like factors research
- Child Nutrition and Water Access
- Dermatologic Treatments and Research
- Diagnosis and treatment of tuberculosis
- Cardiac Arrest and Resuscitation
- Spinal Fractures and Fixation Techniques
- Neurological Disorders and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
McGill University Health Centre
2016-2024
McGill University
2016-2024
Royal Victoria Hospital
2023
Hôpital du Sacré-Cœur de Montréal
2019-2020
Université de Montréal
2019-2020
Montreal Heart Institute
2016
Université Européenne de Bretagne
2011
Background Chronic cough significantly impacts individuals' quality of life and poses challenges for healthcare providers due to limited licensed treatments, side effects available medications, difficulty accessing non-pharmacologic interventions. Understanding priorities research, education, knowledge dissemination from the perspectives individuals with chronic can guide future efforts. This study aimed identify these key in Canada. Study design methods We conducted a cross-sectional using...
Systemic sclerosis (SSc) is thought to be induced by an environmental trigger in genetically predisposed individuals. This study assessed the demographic and clinical characteristics disease severity of silica exposed SSc patients.Data was obtained from Canadian Scleroderma Research Group (CSRG) cohort, containing 1,439 patients (2004-2019). Univariate multivariate logistic regression analyses were performed, determine phenotype silica-exposed patients. Mortality using Cox Survival...
Work-related asthma is highly prevalent and represents a significant societal financial burden worldwide. This State of the Art series article explores epidemiology, clinical features, diagnosis management occupational (OA), which comprises sensitiser-induced irritant-induced (IIA). Sensitiser-induced OA development through sensitisation to substance in workplace. largely underdiagnosed, its manifestations are non-specific, makes challenging. Early accurate comprehensive testing primordial...
Omalizumab is an anti-immunoglobulin E monoclonal antibody used to treat moderate severe chronic idiopathic urticaria, asthma, and nasal polyps. Recent research suggested that omalizumab may enhance the innate antiviral response have anti-inflammatory properties. We aimed investigate efficacy safety of in adults hospitalized for coronavirus disease 2019 (COVID-19) pneumonia. This was a phase II randomized, double blind, placebo-controlled trial comparing with placebo (in addition standard...
We report a diagnostic odyssey of an unusual presentation uremic pleuritis and subsequent successful treatment with low-dose colchicine in patient already on dialysis for end-stage renal disease. To our knowledge, this is the first reported use to treat pleuritis, warranting further exploration consideration clinical practice.
The CIAO trial recently demonstrated a probable clinical benefit of omalizumab in the treatment severe COVID-19; however, mechanism underlying this remains unclear. Therefore, we sought to longitudinally assess impact on serum cytokines patients determine its action.
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications Network Open Cardiology Dermatology Health Forum Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...
<b>Introduction:</b> Global guidelines define chronic cough (CC) as lasting >8 weeks. <b>Objective:</b> To understand physicians' perceptions, attitudes and knowledge of different aspects CC. <b>Methods:</b> Anonymous Canadian web-based survey completed by 101 primary care physicians (PCP) 78 specialists (25 allergists, 28 pulmonologists, 25 ENTs). Diagnostic tests performed were rated from 1 (never perform) to 10 (always perform). <b>Results:</b> The recognition CC a longer than 8 weeks...
<b>Introduction:</b> Nomenclature to describe patients with chronic cough has evolved over the years, and guidelines now include terms such as refractory (RCC), unexplained (UCC), hypersensitivity syndrome (CHS). <b>Objective:</b> To investigate if terminology used by physicians is aligned current guidelines, understand perceived disease burden need for medical education. <b>Methods:</b> Canadian-wide survey of 101 primary care (PCP) 78 specialists (25 allergists, 28 pulmonologists, 25...